Garbers, Christoph, Monhasery, Niloufar, Aparicio-Siegmund, Samadhi, Lokau, Juliane, Baran, Paul, Nowell, Mari Ann, Jones, Simon Arnett  ORCID: https://orcid.org/0000-0001-7297-9711, Rose-John, Stefan and Scheller, Jürgen
2014.
The interleukin-6 receptor Asp358Ala single nucleotide polymorphism rs2228145 confers increased proteolytic conversion rates by ADAM proteases.
Biochimica et Biophysica Acta - Molecular Basis of Disease
1842
(9)
, pp. 1485-1494.
10.1016/j.bbadis.2014.05.018
|
Preview |
PDF
- Accepted Post-Print Version
Download (1MB) | Preview |
Abstract
The pleiotropic activities of Interleukin (IL-)6 are controlled by membrane-bound and soluble forms of the IL-6 receptor (IL-6R) in processes called classic and trans-signaling, respectively. The coding single nucleotide polymorphism (SNP) rs2228145 of the Interleukin 6 receptor (IL-6R Asp358Ala variant) is associated with a 2-fold increase in soluble IL-6R (sIL-6R) serum levels resulting in reduced IL-6-induced C-reactive protein (CRP) production and a reduced risk for coronary heart disease. It was suggested that the increased sIL-6R level leads to decreased IL-6 classic or increased IL-6 trans-signaling. Irrespective of the functional outcome of increased sIL-6R serum level, it is still under debate, whether the increased sIL-6R serum levels emerged from differential splicing or ectodomain shedding. Here we show that increased proteolytic ectodomain shedding mediated by the A Disintegrin and metalloproteinase domain (ADAM) proteases ADAM10 and ADAM17 caused increased sIL-6R serum level in vitro as well as in healthy volunteers homozygous for the IL-6R Asp358Ala allele. Differential splicing of the IL-6R appears to have only a minor effect on sIL-6R level. Increased ectodomain shedding resulted in reduced cell-surface expression of the IL-6R Asp358Ala variant compared to the common IL-6R variant. In conclusion, increased IL-6R ectodomain shedding is a mechanistic explanation for the increased serum IL-6R levels found in persons homozygous for the rs2228145 IL-6R Asp358Ala variant.
| Item Type: | Article |
|---|---|
| Date Type: | Publication |
| Status: | Published |
| Schools: | Schools > Medicine |
| Subjects: | Q Science > QR Microbiology > QR180 Immunology R Medicine > R Medicine (General) |
| Uncontrolled Keywords: | IL-6 trans-signaling; IL-6R; SNP; ADAM17; Limited proteolysis |
| Publisher: | Elsevier |
| ISSN: | 0925-4439 |
| Funders: | Arthritis Research UK |
| Date of First Compliant Deposit: | 30 March 2016 |
| Date of Acceptance: | 20 May 2014 |
| Last Modified: | 05 Feb 2025 22:45 |
| URI: | https://orca.cardiff.ac.uk/id/eprint/78705 |
Citation Data
Cited 100 times in Scopus. View in Scopus. Powered By Scopus® Data
Actions (repository staff only)
 |
Edit Item |
Altmetric
Altmetric